CompletedNCT00150579
SPD465 for ADHD
This study is completed in Global. It is testing SPD465 for ADHD.
In GlobalADHDOtherFrom 18 Years to 55 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT00152022
SPD465 for ADHD
This study is completed in Global. It is testing SPD465 for ADHD.
In GlobalADHDOtherFrom 18 Years to 55 Years
CompletedNCT00734578
SPD503 for ADHD
This study is completed in the United States. It is testing SPD503 for ADHD.
Multiple locations, including DothanADHDOtherFrom 6 Years to 17 Years
CompletedNCT02633527
SPN-812 (Viloxazine Extended-release Capsule) for ADHD
This study is completed in the United States. It is testing SPN-812 (Viloxazine Extended-release Capsule) for ADHD.
In MaitlandADHDOtherFrom 6 Years to 12 Years
CompletedNCT00782080
St. John´s Wort/Valerian Extract for ADHD
This study is completed in Germany. It is testing st.
Multiple locations, including AlzeyADHDOtherFrom 6 Years to 17 Years
CompletedNCT06782763
Task-activated rTMS for Bipolarity
This study is completed in China. It is testing Task-activated rTMS for Bipolarity.
In HangzhouBipolarityOtherFrom 14 Years to 45 Years
Active Not RecruitingNCT07184697
Efficacy and Safety of Task-specific, Biomarker-driven, HD-ctACS inTRD.
This study is active but not recruiting in China. It focuses on Depression.
In ShanghaiDepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
UnknownNCT06270433
Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Desvenlafaxine Succinate Sustained-release Tablets Targeting Anhedonia for depression
This study has an unknown status in China. It is testing Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Desvenlafaxine Succinate Sustained-release Tablets Targeting Anhedonia for depression.
In NanjingDepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
CompletedNCT04641143
Troriluzole for OCD
This study is completed in the United States. It is testing troriluzole for OCD.
Multiple locations, including ChandlerOCDDrugFrom 18 Years to 65 Years
CompletedNCT00202007
Efficacy and Safety Study of Aripiprazole to Treat Schizophrenia
This study is completed in China. It focuses on schizophrenia.
Multiple locations, including GuangzhouSchizophreniaOtherFrom 18 Years to 65 Years
CompletedNCT06419608
BHV-7000 Monotherapy for depression
This study is completed in the United States. It is testing BHV-7000 Monotherapy for depression.
Multiple locations, including PhoenixDepressionDrugFrom 18 Years to 75 Years
CompletedNCT01536210
Combination of Ginkgo Extract and Ginseng Extract for ADHD
This study is completed in South Korea. It is testing combination of Ginkgo Extract and Ginseng Extract for ADHD.
Multiple locations, including Anyang-siADHDOtherFrom 6 Years to 15 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.